fbpx

Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia

2021-05-24T20:04:46+00:00May 12th, 2021|

Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia! We are proud to have been part of this clinical trial and to have worked with this partner who is dedicated to bringing life changing treatments to patients with this rare disease.

To learn more about this trial and future trials, please visit: https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-reports-positive-topline-phase-1-clinical